These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15863261)

  • 1. Endothelins in breast tumour cell invasion.
    Grimshaw MJ
    Cancer Lett; 2005 May; 222(2):129-38. PubMed ID: 15863261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1.
    Wilson JL; Burchell J; Grimshaw MJ
    Cancer Res; 2006 Dec; 66(24):11802-7. PubMed ID: 17178876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of endothelins and their receptors promotes an invasive phenotype of breast tumor cells but is insufficient to induce invasion in benign cells.
    Hagemann T; Binder C; Binder L; Pukrop T; Trümper L; Grimshaw MJ
    DNA Cell Biol; 2005 Nov; 24(11):766-76. PubMed ID: 16274297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelins and hypoxia-inducible factor in cancer.
    Grimshaw MJ
    Endocr Relat Cancer; 2007 Jun; 14(2):233-44. PubMed ID: 17639040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.
    Veeck J; Chorovicer M; Naami A; Breuer E; Zafrakas M; Bektas N; Dürst M; Kristiansen G; Wild PJ; Hartmann A; Knuechel R; Dahl E
    Oncogene; 2008 Jan; 27(6):865-76. PubMed ID: 17653090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for endothelin-2 and its receptors in breast tumor cell invasion.
    Grimshaw MJ; Hagemann T; Ayhan A; Gillett CE; Binder C; Balkwill FR
    Cancer Res; 2004 Apr; 64(7):2461-8. PubMed ID: 15059899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma.
    Lee AH; Pinder SE; Macmillan RD; Mitchell M; Ellis IO; Elston CW; Blamey RW
    Eur J Cancer; 2006 Feb; 42(3):357-62. PubMed ID: 16377180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
    Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma.
    Boldrini L; Gisfredi S; Ursino S; Faviana P; Lucchi M; Melfi F; Mussi A; Basolo F; Fontanini G
    Eur J Cancer; 2005 Dec; 41(18):2828-35. PubMed ID: 16298124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
    Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
    BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristic of the endogenous peptides--endothelins and their role in the connective tissue fibrosis].
    Garncarczyk A; Jurzak M; Gojniczek K
    Wiad Lek; 2008; 61(4-6):126-34. PubMed ID: 18939363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the Endothelin-axis in the different histologic subtypes of renal cell carcinoma: a tissue microarray analysis.
    Herrmann E; Eltze E; Bierer S; Bogemann M; Brinkmann OA; Balnowair H; Hertle L; Wulfing C
    Oncol Rep; 2007 Feb; 17(2):275-80. PubMed ID: 17203161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic relevance of endothelin-B receptor in vulvar cancer.
    Eltze E; Bertolin M; Korsching E; Wülfing P; Maggino T; Lellé R
    Oncol Rep; 2007 Aug; 18(2):305-11. PubMed ID: 17611649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immuno histochemical study of endothelin-1 in breast cancer].
    Lu J; Liang Y; Wang X
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):13-5. PubMed ID: 7656778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia/reoxygenation: a dynamic regulator of lysyl oxidase-facilitated breast cancer migration.
    Postovit LM; Abbott DE; Payne SL; Wheaton WW; Margaryan NV; Sullivan R; Jansen MK; Csiszar K; Hendrix MJ; Kirschmann DA
    J Cell Biochem; 2008 Apr; 103(5):1369-78. PubMed ID: 17685448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.
    Madjd Z; Parsons T; Watson NF; Spendlove I; Ellis I; Durrant LG
    Breast Cancer Res; 2005; 7(5):R780-7. PubMed ID: 16168124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.